FDA Approved: TYMLOS — Original Application (Radius Health, Inc.)

View source ↗

Summary

The FDA approved TYMLOS (abaloparatide) from Radius Health as the original NDA for the treatment of postmenopausal osteoporosis in women at risk for fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Tymlos (abaloparatide)

Snippet

ORIG AP for TYMLOS (ABALOPARATIDE)